| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 李安飞 | 广发证券 | 医药生物 | 26.27% | 29.61% | 24.53% | -2.86% | 1 | -56.96% | 2025-03-27 |
| 2 | 仰佳佳 | 申万宏源 | 医药生物 | 26.26% | 25.21% | 17.51% | 23.08% | 1 | -37.64% | 2025-05-29 |
| 3 | 华挺 | 财通证券 | 医药生物 | 26.26% | 20.37% | 19.11% | -6.67% | 4 | -50.33% | 2025-05-30 |
| 4 | 武煜 | 招银国际 | 医药生物 | 26.23% | 19.18% | 7.60% | -33.33% | 1 | -16.66% | 2025-06-13 |
| 5 | 华挺 | 财通证券 | 医药生物 | 26.21% | 24.02% | 20.83% | -6.67% | 4 | -50.33% | 2025-05-22 |
| 6 | 万鹏辉 | 国海证券 | 医药生物 | 26.17% | 8.73% | 17.34% | 50.00% | 5 | -3.00% | 2025-06-06 |
| 7 | 万鹏辉 | 国海证券 | 医药生物 | 26.17% | 14.65% | 22.54% | 50.00% | 5 | -3.00% | 2025-06-13 |
| 8 | 华挺 | 财通证券 | 医药生物 | 26.16% | 21.26% | 15.71% | -6.67% | 4 | -50.33% | 2025-06-05 |
| 9 | 阳景 | 浦银国际证券 | 医药生物 | 26.16% | 33.06% | 21.73% | 100.00% | 4 | 0.00% | 2025-04-30 |
| 10 | 夏禹 | 国联民生 | 医药生物 | 26.14% | 24.69% | 25.97% | 20.00% | 7 | -52.01% | 2025-04-24 |
| 11 | 周豫 | 太平洋 | 医药生物 | 26.12% | 26.12% | 10.86% | 21.21% | 23 | -55.62% | 2025-07-01 |
| 12 | 张林晚 | 上海证券 | 医药生物 | 26.11% | 21.90% | 17.45% | -100.00% | 1 | -18.93% | 2025-06-23 |
| 13 | 周豫 | 太平洋 | 医药生物 | 26.09% | 20.75% | 15.78% | 21.21% | 23 | -55.62% | 2025-06-16 |
| 14 | 唐寅灏 | 中信证券 | 医药生物 | 26.09% | 18.68% | 26.90% | 85.71% | 12 | -8.47% | 2025-05-16 |
| 15 | 周豫 | 太平洋 | 医药生物 | 26.07% | 17.37% | 16.49% | 21.21% | 23 | -55.62% | 2025-06-09 |
| 16 | 华挺 | 财通证券 | 医药生物 | 26.04% | 25.24% | 14.16% | -6.67% | 4 | -50.33% | 2025-06-25 |
| 17 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 26.03% | 56.69% | 16.86% | 12.50% | 1 | -27.10% | 2025-03-07 |
| 18 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 26.03% | 57.07% | 22.24% | 12.50% | 1 | -27.10% | 2025-03-20 |
| 19 | 阳景 | 浦银国际证券 | 医药生物 | 25.97% | 57.98% | 24.01% | 100.00% | 2 | 0.00% | 2025-03-19 |
| 20 | 仰佳佳 | 申万宏源 | 医药生物 | 25.83% | 36.16% | 10.11% | 23.08% | 1 | -37.64% | 2025-07-10 |